Literature DB >> 29962810

Pseudocarcinomatous Hyperplasia of the Fallopian Tube Mimicking a Tubal Neoplasm: A Rare Entity.

Gireesha Rawal1, Sufian Zaheer1, Amit Kumar Yadav1, Indrani Dhawan1.   

Abstract

Pseudocarcinomatous hyperplasia of the fallopian tube is a rare, reactive response to an underlying inflammatory or neoplastic process. Only a few cases have been reported in literature. It is a benign condition that mimics a malignant neoplasm clinically and radiologically. Thus, a preoperative diagnosis of this entity is important to avoid radical surgical treatment. We report a case of pseudocarcinomatous hyperplasia of the fallopian tube in a 27-year-old female, which was clinically and radiologically thought to be a tubal neoplasm. The approach to such a case and the differentiating features from adenocarcinoma have also been discussed.

Entities:  

Keywords:  Fallopian tube; neoplasm; pseudocarcinomatous hyperplasia

Year:  2018        PMID: 29962810      PMCID: PMC6006802          DOI: 10.4103/jmh.JMH_113_17

Source DB:  PubMed          Journal:  J Midlife Health


  4 in total

1.  Pseudocarcinomatous Hyperplasia of the Fallopian Tubes which was Associated with Female Genital Tract Tuberculosis, Histologically Mimicking Tubal Adenocarcinoma: A Diagnostic Challenge.

Authors:  Sonam Gupta; Prem Singh; Jyoti Bala; Deeba Mushtaq; Ankita Goyal
Journal:  J Clin Diagn Res       Date:  2012-10

2.  Pseudocarcinomatous hyperplasia of the fallopian tube associated with salpingitis. A report of 14 cases.

Authors:  A N Cheung; R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1994-11       Impact factor: 6.394

3.  Pseudocarcinomatous hyperplasia of the fallopian tube mimicking tubal cancer: a radiological and pathological diagnostic challenge.

Authors:  Nam Kyung Lee; Kyung Un Choi; Ga Jin Han; Byung Su Kwon; Yong Jung Song; Dong Soo Suh; Ki Hyung Kim
Journal:  J Ovarian Res       Date:  2016-11-14       Impact factor: 4.234

4.  Clinical and survival analysis of 36 cases of primary fallopian tube carcinoma.

Authors:  Ying Ma; Wei Duan
Journal:  World J Surg Oncol       Date:  2014-10-12       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.